Navigation Links
Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board
Date:2/12/2009

ROCKVILLE, Md., Feb. 12 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today that James Sasser, former Senator (D-Tennessee) and former Ambassador to the People's Republic of China, has joined the Neuralstem Advisory Board and will serve as senior advisor on China.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

Senator Sasser was elected to the United States Senate from Tennessee in 1976 where he served for eighteen years. During that time, Senator Sasser served as Chairman of the Senate Budget Committee as well as Chairman of various subcommittees on the Appropriations Committee, the Banking Committee and the Governmental Affairs committee. In 1995, Senator Sasser was appointed a Fellow at the Kennedy School at Harvard University. While at Harvard, he was appointed Ambassador to the People's Republic of China by President Bill Clinton and served in that capacity for almost four years. He played a pivotal role in stabilizing Sino-US relations and traveled with President Jiang Zemin on his historic State visit to the United States.

"We are extremely proud and excited to have Senator Sasser come on board," said Neuralstem President & CEO Richard Garr. "The company is deeply committed to developing and commercializing our cell therapies in China. Senator Sasser brings an unmatched wealth of knowledge and experience with both the Chinese business and government communities." Neuralstem is in talks with leading medical facilities in China, where the company intends to target spinal cord injury.

"I am excited to help Neuralstem move forward in China," said Senator Sasser. "This new technology is a leading example of American innovation, and has the potential to help so many people all over the world. I am looking forward to being a part of that."

Senator Sasser also serves on the Board of Trustees of the National Geographic Society, on the Board of the Elliott School of International Relations at George Washington University and is a member of the Council on Foreign Relations. He is presently a senior advisor to FedEx Corporation and senior counselor to APCO Worldwide in Washington, DC. He has served as a consultant to other US corporations doing business in China, including Ford Motor Company, the former Unocal Corporation, and Brown-Forman Corporation. Senator Sasser was educated at Vanderbilt University where he received a Bachelor of Arts degree in 1958 and a Doctor of Jurisprudence degree from Vanderbilt Law School in 1961. In 1998, Senator Sasser was selected as a distinguished alumnus of Vanderbilt Law School. He has also served in the U.S. Marine Corps.

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and Amyotrophic Lateral Sclerosis (ALS). The Company filed an IND (Investigational New Drug) application with the FDA for ALS clinical trials in December, 2008, and has entered into a collaborative agreement with Albert-Ludwigs-University, in Freiburg, Germany, to develop clinical trials for Huntington's disease.

In pre-clinical work, the company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10- KSB for the year ended December 31, 2007 and the quarterly report on form 10-Q for the period ended September 30, 2008.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Senator Arlen Specter Addresses Constituents on Americas Healthcare Crisis
2. FRC Applauds the Withdrawal of Senator Daschle for HHS
3. Comment of Senator Patrick Leahy on President Obamas Decision to Reverse The Mexico City Policy
4. Madison-Area Optometrists Partner With Senator Kohl in Improving Infant Eye and Vision Care
5. Senator Sam Brownback and Rep. Cathy McMorris Rodgers to Speak at Blogs for Life 2009
6. Lung Cancer Alliance Hails Massachusetts State Senator for Taking Lead on Lung Cancer
7. Senators Lugar, Dodd, Boxer and Representatives Lee and McCollum Receive GAC Childrens Champion Award
8. Senator Schumer Speaks to 4,900 AARP Members Pledging Bipartisan Action on Nations Health and Economic Crises
9. Senator Reid, Reps. Slaughter and DeGette Introduce the Prevention First Act
10. US Oncology Applauds Senator Daschles Appointment as Director of President-Elect Obamas New White House Office of Health Reform
11. Comment of Senator Patrick Leahy (D-Vt.) on President-elect Obamas Choice of Former Senator Tom Daschle to Head The Department of Health and Human Services and A New White House Office of Health Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 04, 2016 , ... ... and global construction firms representing the Construction Industry Safety Initiative (CISI) and the ... one purpose: to inspire everyone in the industry to be leaders in safety. ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... on Denver Business Journal, patients report dissatisfaction with numerous issues related to medical ... personnel, issues with billing, and poor bedside manner from hospital staff. Commenting on ...
(Date:5/3/2016)... ... May 03, 2016 , ... Healing Cancer in This Century is ... move toward recovery and is offered by creator and visionary Carlos Caridad. Healing ... Radio show considering medical and healing modalities of the fields of Integrative, Alternative, ...
(Date:5/3/2016)... ... 2016 , ... With the opioid epidemic now at the forefront, attention has ... Alcohol and its misuse causes long-term consequences for all aspects of society, from ... those 65 years and older. In addition, there is the long term affects ...
(Date:5/3/2016)... Chicago (PRWEB) , ... May 03, 2016 , ... ... has hired award-winning creative director Joe Ferrazano to serve in the newly created ... Ferrazano will be overseeing the agency’s creative efforts in the Chicago and LA ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... TUSTIN, Calif. , May 3, 2016 /PRNewswire/ ... science teaching tool that shows how a cleanroom ... for classroom discussions about science and technology. ... Manager said, "As a technology company, SSF enthusiastically ... program to help educators foster the next generation ...
(Date:5/3/2016)... PUNE, India , May 3, 2016 /PRNewswire/ ... Market 2016 Research Report provides a basic overview ... manufacturing technology, post which the surgical mesh report ... the market. Complete report on Surgical ... company profiles and 98 tables and figures is ...
(Date:5/2/2016)... Leading Economies with Fastest Real GDP Annual Percentage Change, 2015  ... 7.3, , Source: IMF and TechSci Research   ... Brazil , Russia , India , ... the fastest GDP growth during the first decade of the 21 st ... Brazil and Russia , along with policy ...
Breaking Medicine Technology: